A study released Friday found that kid-size doses of Pfizer’s Covid vaccine are nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds.
Related Articles
-
Israel launches Covid-19 vaccination pass
JERUSALEM — Israel reopened swathes of its economy including malls and leisure facilities on Sunday, with the government saying...
-
Low on beds and oxygen, India sets global record for new Covid cases
NEW DELHI — India reported a global record of more than 314,000 new infections Thursday as a grim coronavirus...
-
Revamped ‘Cancer Moonshot’ could prevent deaths and improve quality of life for survivors
President Joe Biden’s ambitious “Cancer Moonshot” relaunch will not only prevent deaths, it could also significantly improve the quality...
-
‘This will shut us down’: HIV prevention clinics brace for Gilead reimbursement cuts
Tony Christon-Walker was determined to set up an HIV prevention clinic in Birmingham, Alabama, that would succeed where others...
-
Johnson & Johnson reaches $230 million opioid settlement with New York
Johnson & Johnson agreed to pay about $230 million over the next nine years to resolve claims made by...
-
The Navajo Nation ‘didn’t politicize wearing masks.’ Its efforts are paying off — for now.
At its nadir, the Navajo Nation had the highest rate of Covid-19 infections per capita in the United States,...
-
Is this the biggest Covid summer wave ever?
The U.S. is in what may end up being its biggest summer wave of Covid, with no end yet...
-
Veterinarian who got monkeypox years ago describes lesions and flu-like symptoms
A veterinarian who contracted monkeypox during a U.S. outbreak in 2003 described the “scary” ordeal of becoming suddenly ill...
Recent Comments